The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways
Open accessAbstract
The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is a functional homologue of the tumor necrosis factor receptor family and contributes substantially to the oncogenic potential of EBV through activation of nuclear factor κB (NF-κB). MicroRNAs (miRNAs) are a class of small RNA molecules that are involved in the regulation of cellular processes such as growth, development, and apoptosis and have recently been linked to cancer phenotypes. Through miRNA microarray analysis, we demonstrate that LMP1 dysregulates the expression of several cellular miRNAs, including the most highly regulated of these, miR-146a. Quantitative reverse transcription-PCR analysis confirmed induced expression of miR-146a by LMP1. Analysis of miR-146a expression in EBV latency type III and type I cell lines revealed substantial expression of miR-146a in type III (which express LMP1) but not in type I cell lines. Reporter studies demonstrated that LMP1 induces miR-146a predominantly through two NF-κB binding sites in the miR-146a promoter and identified a role for an Oct-1 site in conferring basal and induced expression. Array analysis of cellular mRNAs expressed in Akata cells transduced with an miR-146a-expressing retrovirus identified genes that are directly or indirectly regulated by miR-146a, including a group of interferon-responsive genes that are inhibited by miR-146a. Since miR-146a is known to be induced by agents that activate the interferon response pathway (including LMP1), these results suggest that miR-146a functions in a negative feedback loop to modulate the intensity and/or duration of the interferon response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 1×
“Interestingly, like miR-155, elevated miR-146a has been correlated with certain tumor types (13, 39, 41).”
BackgroundIRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · cited 1×
“Knockout mice deficient in BIC/ miR-155 were unable to generate a protective immune response in a Salmonella postimmunization challenge model and were impaired in antibody production, class switching, and production of interleukin-2 (IL-2) and IFN- when immunized with tetanus toxin fragment C (35).”
Cited by
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
MicroRNAs: new regulators of immune cell development and function
Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., & Taganov, K. D. (2008) · Nature Immunology · doi:10.1038/ni.f.209 · Cited by 1,088
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Jazdzewski, K., Murray, E. L., Franssila, K., Jarzab, B., Schoenberg, D. R., & de la Chapelle, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802682105 · Cited by 842
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
Self-citationHou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900707 · Cited by 739
Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24436 · Cited by 735
MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda, S. K., & Alahari, S. K. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9188-5 · Cited by 682
Viruses, microRNAs, and Host Interactions
Skalsky, R. L., & Cullen, B. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134243 · Cited by 676
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z.-H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 638
The evolution of RNAi as a defence against viruses and transposable elements
Obbard, D. J., Gordon, K. H. J., Buck, A. H., & Jiggins, F. M. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0168 · Cited by 516
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Dai, R., & Ahmed, S. A. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.007 · Cited by 444
MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response
Saba, R., Sorensen, D. L., & Booth, S. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00578 · Cited by 427
Viral and Cellular MicroRNAs as Determinants of Viral Pathogenesis and Immunity
Gottwein, E., & Cullen, B. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.002 · Cited by 405
Cullen, B. R. (2006) · Nature Genetics · doi:10.1038/ng1793 · Cited by 404
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
Tahamtan, A., Teymoori-Rad, M., Nakstad, B., & Salimi, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01377 · Cited by 357
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Skalsky, R. L., Corcoran, D. L., Gottwein, E., Frank, C. L., Kang, D., Hafner, M., Nusbaum, J. D., Feederle, R., Delecluse, H.-J., Luftig, M. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002484 · Cited by 352
Alterations in MicroRNA Expression Contribute to Fatty Acid–Induced Pancreatic β-Cell Dysfunction
Lovis, P., Roggli, E., Laybutt, D. R., Gattesco, S., Yang, J.-Y., Widmann, C., Abderrahmani, A., & Regazzi, R. (2008) · Diabetes · doi:10.2337/db07-1252 · Cited by 345
Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer
Jazdzewski, K., Liyanarachchi, S., Swierniak, M., Pachucki, J., Ringel, M. D., Jarzab, B., & de la Chapelle, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812591106 · Cited by 304
MicroRNA in TLR signaling and endotoxin tolerance
Nahid, M. A., Satoh, M., & Chan, E. K. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.26 · Cited by 294
Curtale, G., Citarella, F., Carissimi, C., Goldoni, M., Carucci, N., Fulci, V., Franceschini, D., Meloni, F., Barnaba, V., & Macino, G. (2010) · Blood · doi:10.1182/blood-2009-06-225987 · Cited by 263
Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J., & Flemington, E. K. (2008) · Journal of Virology · doi:10.1128/jvi.02380-07 · Cited by 261
Self-citationGatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., & Mallardo, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn666 · Cited by 254
Adding fuel to fire: microRNAs as a new class of mediators of inflammation
Sheedy, F. J., & O'Neill, L. A. J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.100289 · Cited by 246
MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways
He, X., Jing, Z., & Cheng, G. (2014) · BioMed Research International · doi:10.1155/2014/945169 · Cited by 238
“In addition, miR155 expression is induced in the NF-𝜅B-dependent manner in various cell types after many stimuli, including LPS and LMP1, the viral latent protein of the Epstein-Barr virus (EBV) [36, 37].miR-146a expression can also be induced through the NF-𝜅B-dependent pathway in response to various immune mediators…”
BackgroundInfluentialMiR-146a in Immunity and Disease
Rusca, N., & Monticelli, S. (2011) · Molecular Biology International · doi:10.4061/2011/437301 · Cited by 231
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
Labbaye, C., & Testa, U. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-13 · Cited by 228
MicroRNA-146a and Human Disease
Li, L., Chen, X.-P., & Li, Y.-J. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02383.x · Cited by 217
MicroRNAs, new effectors and regulators of NF‐κB
Boldin, M. P., & Baltimore, D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01089.x · Cited by 199
Jurkin, J., Schichl, Y. M., Koeffel, R., Bauer, T., Richter, S., Konradi, S., Gesslbauer, B., & Strobl, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903021 · Cited by 139
Pichler, K., Schneider, G., & Grassmann, R. (2008) · Retrovirology · doi:10.1186/1742-4690-5-100 · Cited by 109
Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients
Paraboschi, E. M., Soldà, G., Gemmati, D., Orioli, E., Zeri, G., Benedetti, M. D., Salviati, A., Barizzone, N., Leone, M., Duga, S., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128695 · Cited by 102
Forte, E., Salinas, R. E., Chang, C., Zhou, T., Linnstaedt, S. D., Gottwein, E., Jacobs, C., Jima, D., Li, Q.-J., Dave, S. S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07056-11 · Cited by 97
MicroRNA-146a disrupts hematopoietic differentiation and survival
Starczynowski, D. T., Kuchenbauer, F., Wegrzyn, J., Rouhi, A., Petriv, O., Hansen, C. L., Humphries, R. K., & Karsan, A. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2010.09.011 · Cited by 84
Metadata
- Authors
- Cameron, J. E., Yin, Q., Fewell, C., Lacey, M., McBride, J., Wang, X., Lin, Z., Schaefer, B. C., & Flemington, E. K.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-02-15
- Volume
- 82
- Issue
- 4
- Pages
- 1946-1958
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2155898804
- Cited by
- 310
- References
- 42
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.